These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8636811)

  • 1. Total and functional antibody response to a quadrivalent meningococcal polysaccharide vaccine among children.
    King WJ; MacDonald NE; Wells G; Huang J; Allen U; Chan F; Ferris W; Diaz-Mitoma F; Ashton F
    J Pediatr; 1996 Feb; 128(2):196-202. PubMed ID: 8636811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-dependent Neisseria meningitidis serogroup C class-specific antibody concentrations and bactericidal titers in sera from young children from Montana immunized with a licensed polysaccharide vaccine.
    Maslanka SE; Tappero JW; Plikaytis BD; Brumberg RS; Dykes JK; Gheesling LL; Donaldson KB; Schuchat A; Pullman J; Jones M; Bushmaker J; Carlone GM
    Infect Immun; 1998 Jun; 66(6):2453-9. PubMed ID: 9596702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related immunogenicity of meningococcal polysaccharide vaccine in aboriginal children and adolescents living in a Northern Manitoba reserve community.
    Law BJ; Rosenberg T; MacDonald NE; Ashton FE; Huang JC; King WJ; Ferris WJ; Gray GJ
    Pediatr Infect Dis J; 1998 Oct; 17(10):860-4. PubMed ID: 9802625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine.
    Robertson CA; Greenberg DP; Hedrick J; Pichichero M; Decker MD; Saunders M
    Vaccine; 2016 Oct; 34(44):5273-5278. PubMed ID: 27642132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adolescent meningococcal serogroup A, W and Y immune responses following immunization with quadrivalent meningococcal A, C, W and Y conjugate vaccine: Optimal age for vaccination.
    van Ravenhorst MB; van der Klis FRM; van Rooijen DM; Sanders EAM; Berbers GAM
    Vaccine; 2017 Aug; 35(36):4753-4760. PubMed ID: 28647167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine.
    Weinberg GA; Einhorn MS; Lenoir AA; Granoff PD; Granoff DM
    J Pediatr; 1987 Jul; 111(1):22-7. PubMed ID: 3110388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and immunogenicity of a serogroups A/C Neisseria meningitidis oligosaccharide-protein conjugate vaccine in young children. A randomized controlled trial.
    Lieberman JM; Chiu SS; Wong VK; Partidge S; Chang SJ; Chiu CY; Gheesling LL; Carlone GM; Ward JI
    JAMA; 1996 May; 275(19):1499-503. PubMed ID: 8622225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy.
    Milagres LG; Ramos SR; Sacchi CT; Melles CE; Vieira VS; Sato H; Brito GS; Moraes JC; Frasch CE
    Infect Immun; 1994 Oct; 62(10):4419-24. PubMed ID: 7927704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine.
    Fijen CA; Kuijper EJ; Drogari-Apiranthitou M; Van Leeuwen Y; Daha MR; Dankert J
    Clin Exp Immunol; 1998 Dec; 114(3):362-9. PubMed ID: 9844044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group.
    Maslanka SE; Gheesling LL; Libutti DE; Donaldson KB; Harakeh HS; Dykes JK; Arhin FF; Devi SJ; Frasch CE; Huang JC; Kriz-Kuzemenska P; Lemmon RD; Lorange M; Peeters CC; Quataert S; Tai JY; Carlone GM
    Clin Diagn Lab Immunol; 1997 Mar; 4(2):156-67. PubMed ID: 9067649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of antibodies against tetravalent meningococcal polysaccharides in revaccinated complement-deficient patients.
    Drogari-Apiranthitou M; Fijen CA; Van De Beek D; Hensen EF; Dankert J; Kuijper EJ
    Clin Exp Immunol; 2000 Feb; 119(2):311-6. PubMed ID: 10632668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meningococcal serogroup C immunogenicity, antibody persistence and memory B-cells induced by the monovalent meningococcal serogroup C versus quadrivalent meningococcal serogroup ACWY conjugate booster vaccine: A randomized controlled trial.
    van Ravenhorst MB; van der Klis FRM; van Rooijen DM; Knol MJ; Stoof SP; Sanders EAM; Berbers GAM
    Vaccine; 2017 Aug; 35(36):4745-4752. PubMed ID: 28668575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of meningococcal serogroup C-specific antibody levels in British Columbian children and adolescents.
    Mitchell LA; Ochnio JJ; Glover C; Lee AY; Ho MK; Bell A
    J Infect Dis; 1996 Apr; 173(4):1009-13. PubMed ID: 8603941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis for protection rate and antibody levels of epidemic cerebrospinal meningitis among children aged between 3-23 months in Liuzhou, in 2012].
    Cui XL; Wu X; Li MQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Dec; 50(12):1079-1083. PubMed ID: 28057112
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunogenicity and reactogenicity of a group C meningococcal conjugate vaccine compared with a group A+C meningococcal polysaccharide vaccine in adolescents in a randomised observer-blind controlled trial.
    Choo S; Zuckerman J; Goilav C; Hatzmann E; Everard J; Finn A
    Vaccine; 2000 Jun; 18(24):2686-92. PubMed ID: 10781855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine.
    Leach A; Twumasi PA; Kumah S; Banya WS; Jaffar S; Forrest BD; Granoff DM; LiButti DE; Carlone GM; Pais LB; Broome CV; Greenwood BM
    J Infect Dis; 1997 Jan; 175(1):200-4. PubMed ID: 8985221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of immunological memory in UK infants by a meningococcal A/C conjugate vaccine.
    Borrow R; Fox AJ; Richmond PC; Clark S; Sadler F; Findlow J; Morris R; Begg NT; Cartwright KA
    Epidemiol Infect; 2000 Jun; 124(3):427-32. PubMed ID: 10982066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration of antibody response after meningococcal polysaccharide vaccination in US Air Force personnel.
    Zangwill KM; Stout RW; Carlone GM; Pais L; Harekeh H; Mitchell S; Wolfe WH; Blackwood V; Plikaytis BD; Wenger JD
    J Infect Dis; 1994 Apr; 169(4):847-52. PubMed ID: 8133100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody response after immunization of Brazilian children with serogroup C meningococcal polysaccharide noncovalently complexed with outer membrane proteins.
    Milagres LG; Lemos AP; Meles CE; Silva EL; Ferreira LH; Souza JA; Carlone GM
    Braz J Med Biol Res; 1995 Sep; 28(9):981-9. PubMed ID: 8580887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum antibodies to capsular polysaccharide vaccine of group A and C Neisseria meningitidis in military recruits in Italy.
    Occhionero M; Usai G; Di Martino M; Le Moli S; Stroffolini T; Mastrantonio P
    Allergol Immunopathol (Madr); 1991; 19(1):39-41. PubMed ID: 1950941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.